Grants and Contributions:
Title:
Optimize Accuracy and Computational Cost of Algorithm for CPAP and Develop Intervention Protocols
Agreement Number:
995984
Agreement Value:
$176,772.00
Agreement Date:
Sep 1, 2022 - May 31, 2023
Description:
NovaResp Technologies Incorporated is a Canadian based corporation founded in 2016 with the goal of developing adaptive, self-learning airway management and providing truly proactive adaptation to patients’ respiratory needs. The company’s lead product – cMAP™- (Continuous monitoring of airway pressure) is a respiratory monitoring device and algorithm that can help positive airway pressure (PAP) machines respond proactively resulting in a safer, more comfortable solution for patients suffering from Sleep Apnea. The purpose of this project is to optimize cMAP™ to improve accuracy of the predictive, self-learning capabilities, while reducing computational cost.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Halifax, Nova Scotia, CA B3H 0A8
Reference Number:
172-2022-2023-Q3-995984
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
754173524
Recipient Type:
For-profit organization
Recipient's Legal Name:
NovaResp Technologies Inc.
Federal Riding Name:
Halifax
Federal Riding Number:
12005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512